Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker MDLN
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | SCHEDULE 13G | MDLN Medline Inc. | Capital Research Global Investors | 47.77M | 5.4% | SCHEDULE 13G ↗ |
| Nov 6, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Hux Investment Pte. Ltd. | 59.41M | 6.8% | SCHEDULE 13G/A ↗ |
| Nov 6, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | GIC Special Investments Private Limited | 59.41M | 6.8% | SCHEDULE 13G/A ↗ |
| Nov 6, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | GIC Private Limited | 74.63M | 8.5% | SCHEDULE 13G/A ↗ |
| Oct 30, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Hux Investment Pte. Ltd. | 91.56M | 10.4% | SCHEDULE 13G/A ↗ |
| Oct 30, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | GIC Special Investments Private Limited | 91.56M | 10.4% | SCHEDULE 13G/A ↗ |
| Oct 30, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | GIC Private Limited | 114.36M | 13.0% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | H&F Corporate Investors X, Ltd. | 153.33M | 16.0% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Hellman & Friedman Capital Partners X, L.P. | 82.47M | 8.6% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Mend Investment Holdings GP, LLC | 82.47M | 8.6% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Mend Partners GP, LLC | 3.42M | 0.4% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Hellman & Friedman Investors X, L.P. | 153.33M | 16.0% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Mend Investment Holdings I, L.P. | 82.47M | 8.6% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Mend Partners II, L.P. | 3.42M | 0.4% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | HFCP X (Parallel - A), L.P. | 6.38M | 0.7% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Hellman & Friedman Capital Partners X (Parallel), L.P. | 61.05M | 6.4% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Stephen A. Schwarzman | 153.33M | 16.5% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Blackstone Group Management L.L.C. | 153.33M | 16.5% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Blackstone Inc. | 153.33M | 16.5% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Blackstone Holdings I/II GP L.L.C. | 153.33M | 16.5% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Blackstone Holdings II L.P. | 153.33M | 16.5% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Bma VIII L.L.C. | 153.33M | 16.5% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | BCP 8 Holdings Mozart Manager L.L.C. | 51.55M | 5.6% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Blackstone Management Associates VIII L.P. | 101.78M | 11.0% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | BCP Mozart Aggregator L.P. | 44.78M | 4.9% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | BX Mozart ML-1 Holdco GP L.L.C. | 44.78M | 4.9% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | BX Mozart ML-2 Holdco GP L.L.C. | 89.54M | 10.2% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Mozart Aggregator II LP | 91.53M | 10.5% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Mozart Aggregator UNLV Holdco L.P. | 6.77M | 0.8% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Mozart Aggregator II UNLV Holdco L.P. | 10.25M | 1.2% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | BX Mozart ML-1 Holdco L.P. | 44.78M | 4.9% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | BX Mozart ML-2 Holdco L.P. | 89.54M | 10.2% | SCHEDULE 13G/A ↗ |
| Aug 6, 2026 | SCHEDULE 13G | MDLN Medline Inc. | Abigail P. Johnson | 46.93M | 5.5% | SCHEDULE 13G ↗ |
| Aug 6, 2026 | SCHEDULE 13G | MDLN Medline Inc. | FMR LLC | 46.93M | 5.5% | SCHEDULE 13G ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CP Circle ML-7 Holdco, L.P. | 15.33M | 1.8% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CP Circle ML-6 Holdco, L.P. | 2.12M | 0.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CP Circle ML-5 Holdco, L.P. | 5.75M | 0.7% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CP Circle ML-4 Holdco, L.P. | 23.16M | 2.7% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CP Circle ML-3 Holdco, L.P. | 50.72M | 6.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CP Circle ML-2 Holdco, L.P. | 233,231 | 0.0% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CP Circle ML Holdco GP, LLC | 97.31M | 11.5% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CP Circle ML-1 Holdco, L.P. | 48.28M | 5.4% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CP Circle ML-1 Holdco GP, LLC | 48.28M | 5.4% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | TC Group VII, L.P. | 145.59M | 16.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | TC Group VII, L.L.C. | 145.59M | 16.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | TC Group Cayman Investment Holdings Sub L.P. | 145.59M | 16.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | TC Group Cayman Investment Holdings, L.P. | 145.59M | 16.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Carlyle Holdings II L.L.C. | 145.59M | 16.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | Carlyle Holdings II GP L.L.C. | 145.59M | 16.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | MDLN Medline Inc. | CPEP Circle Holdings, L.P. | 728,604 | 0.1% | SCHEDULE 13G/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 10:40 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances